Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elham Pishali Bejestani"'
Autor:
Marina Natoli, Petra Herzig, Elham Pishali Bejestani, Melanie Buchi, Reto Ritschard, G. Kenneth Lloyd, Ramon Mohanlal, James R. Tonra, Lan Huang, Viola Heinzelmann, Marta Trüb, Alfred Zippelius, Abhishek S. Kashyap
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Reprogramming tumor infiltrating myeloid cells to elicit pro-inflammatory responses is an exciting therapeutic maneouver to improve anti-tumor responses. We recently demonstrated that a distinct microtubule-targeting drug, plinabulin—a clinical-sta
Externí odkaz:
https://doaj.org/article/d21b4ca37c104d1593f619178ef9f5c2
Autor:
Elham Pishali Bejestani, Marc Cartellieri, Ralf Bergmann, Armin Ehninger, Simon Loff, Michael Kramer, Johannes Spehr, Antje Dietrich, Anja Feldmann, Susann Albert, Martin Wermke, Michael Baumann, Mechthild Krause, Martin Bornhäuser, Gerhard Ehninger, Michael Bachmann, Malte von Bonin
Publikováno v:
OncoImmunology, Vol 6, Iss 10 (2017)
The universal modular chimeric antigen receptor (UniCAR) platform redirects CAR-T cells using a separated, soluble targeting module with a short half-life. This segregation allows precise controllability and flexibility. Herein we show that the UniCA
Externí odkaz:
https://doaj.org/article/4bae5199a0ed4757af8ff2122c120682
Autor:
Manja Wobus, Martin Bornhäuser, Uwe Freudenberg, Laura J. Bray, Malte von Bonin, Abhishek Dhawan, Carsten Werner, Elham Pishali Bejestani, Lorenz C. Hofbauer
Publikováno v:
Stem Cells. 34:2224-2235
Skeletal metastasis of breast cancer is associated with a poor prognosis and significant morbidity. Investigations in other solid tumors have revealed an impairment in hematopoietic function upon bone marrow invasion. However, the interaction between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e33fb79107c6bc86ee961e1aac1b316
https://doi.org/10.1002/stem.2384
https://doi.org/10.1002/stem.2384
Autor:
Katrin Lambert, Elham Pishali Bejestani, Malte von Bonin, Michael Brand, Dimitra Alexopoulou, Martin Kräter, Andreas Dahl, Friedrich Stölzel, Martin Stöter, Jens Friedrichs, Guruchandar Arulmozhivarman, Manja Wobus, Nona Shayegi, Marc Bickle, Jochen Hampe, Martin Bornhäuser, Katrin Müller
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
The identification of small molecules that either increase the number and/or enhance the activity of human hematopoietic stem and progenitor cells (hHSPCs) during ex vivo expansion remains challenging. We used an unbiased in vivo chemical screen in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e15f2bc3562de8ee8b54d72a12c4fb2c
Autor:
Elham Pishali Bejestani, Anja Feldmann, Gerhard Ehninger, Ralf Bergmann, Mechthild Krause, Marc Cartellieri, Susann Albert, Johannes Spehr, Malte von Bonin, Michael Baumann, Antje Dietrich, Simon Loff, Martin Wermke, Martin Bornhäuser, Michael Bachmann, Armin Ehninger, Michael Kramer
Publikováno v:
OncoImmunology 6(2017)10, 1342909
OncoImmunology, Vol 6, Iss 10 (2017)
OncoImmunology, Vol 6, Iss 10 (2017)
The universal modular chimeric antigen receptor (UniCAR) platform redirects CAR-T cells using a separated, soluble targeting module with a short half-life. This segregation allows precise controllability and flexibility. Herein we show that the UniCA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fdab3a48a5fea97a33b0e160e6892b0
https://pubmed.ncbi.nlm.nih.gov/29123951
https://pubmed.ncbi.nlm.nih.gov/29123951
Autor:
Alfred Zippelius, James R. Tonra, Melanie Buchi, G. Kenneth Lloyd, Lan Huang, Abhishek S. Kashyap, Petra Herzig, Reto Ritschard, Elham Pishali Bejestani, Ramon Mohanlal
Publikováno v:
Cancer Research. 79:5030-5030
The M2 phenotype is dominant in tumor associated macrophages (TAMs) and correlates with poor prognosis. As M1 polarized macrophages possess anti-tumor functions, in vivo reprogramming of macrophages is a promising strategy for cancer treatment. We re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::571b1e764903c848ffc907b228c6999d
https://doi.org/10.1158/1538-7445.am2019-5030
https://doi.org/10.1158/1538-7445.am2019-5030
Autor:
Elham Pishali Bejestani, Marc Cartellieri, Michael Bachmann, Mechthild Krause, Malte von Bonin, Gerhard Ehninger, Michael H. Baumann, Armin Ehninger
Publikováno v:
Cancer Immunology Research. 4:B021-B021
Background: The adoptive transfer of T cell engineered with chimeric antigen receptors (CARs) is currently considered a highly promising therapeutic option for treating so far incurable malignant diseases. In order to reduce adverse reactions associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3298e88220276711dfc590d3c09f98f
https://doi.org/10.1158/2326-6074.cricimteatiaacr15-b021
https://doi.org/10.1158/2326-6074.cricimteatiaacr15-b021
Autor:
Anja Feldmann, Simon Loff, Claudia Arndt, Elham Pishali Bejestani, Michael Bachmann, Marc Cartellieri, Gerhard Ehninger, Stefanie Koristka, Malte von Bonin, Armin Ehninger
Publikováno v:
Blood. 126:5549-5549
The adoptive transfer of T cells engineered with chimeric antigen receptors (CARs) is currently considered as a highly promising therapeutic option for treatment of otherwise incurable malignant diseases. CARs combine the cellular and humoral arm of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8caa4bbe55fd1cede39c896502b65c88
https://doi.org/10.1182/blood.v126.23.5549.5549
https://doi.org/10.1182/blood.v126.23.5549.5549